Bambusa Therapeutics (NASDAQ:BBTX) Director Ra Capital Management, L.P. Buys 453,820 Shares of Stock November 4, 2026 by InsiderTrades.com Share Key Points RA Capital Management purchased 453,820 Bambusa Therapeutics shares on October 30 at an average price of $14.63, for about $6.64 million. RA Capital also bought 2.5 million shares on November 2 at $16 each, a $40 million transaction. Bambusa shares opened at $16 on Wednesday and have traded between $13.60 and $17.42 over the past 52 weeks. Bambusa Therapeutics, Inc. (NASDAQ:BBTX - Get Free Report) Director Ra Capital Management, L.P. purchased 453,820 shares of the business's stock in a transaction dated Friday, October 30th. The shares were purchased at an average price of $14.63 per share, for a total transaction of $6,639,386.60. Following the acquisition, the director directly owned 453,820 shares of the company's stock, valued at $6,639,386.60. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Ra Capital Management, L.P. also recently made the following trade(s): On Monday, November 2nd, Ra Capital Management, L.P. purchased 2,500,000 shares of Bambusa Therapeutics stock. The stock was purchased at an average price of $16.00 per share, with a total value of $40,000,000.00. Bambusa Therapeutics Stock PerformanceShares of NASDAQ:BBTX opened at $16.00 on Wednesday. Bambusa Therapeutics, Inc. has a 52 week low of $13.60 and a 52 week high of $17.42. See AlsoFive stocks we like better than Bambusa TherapeuticsMarriott's Earnings Beat Shows Why It's More Than a Bet on Travel DemandFranklin Templeton's New ETFs Turn Stock Dividends Into Bitcoin—What's the Catch?Apple's Earnings Beat Comes With a Catch for Investors Heading Into the HolidaysPalantir's $2.3 Billion Quarter Puts Its Premium Valuation to the TestThis instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at Bambusa Therapeutics? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Bambusa Therapeutics and related companies. From Our PartnersDr. Ron Paul: “It’s time to prepare”The Pentagon has plans for military bases to survive a 90-day disaster. A former Defense Intelligence Agency s...Stansberry Research | SponsoredU.S. Army Advances 75-Year Rare Earth Deal With Nasdaq FirmThe Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just sig...The Tomorrow Investor | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times th...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredGet more income from your savings without trading optionsWant investment income without trading options yourself? Paycheck ETFs let fund managers handle the options tr...Investors Alley | Sponsored Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersDr. Ron Paul: “It’s time to prepare”The Pentagon has plans for military bases to survive a 90-day disaster. A former Defense Intelligence Agency s...Stansberry Research | SponsoredU.S. Army Advances 75-Year Rare Earth Deal With Nasdaq FirmThe Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just sig...The Tomorrow Investor | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times th...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | Sponsored Most Read This MonthInsider Buying Signals Opportunity in H.B. Fuller, FocalTherics, CardinalDatadog’s Rally Has Insiders Selling—Can It Keep Climbing?Insider Buying Is Rising at These 3 Regional Banks, But the Details MatterInsiders Are Selling These 5 AI Stocks—Should You Worry?Digi Power X (NASDAQ:DGXX) Stock: Insider Michel Amar Acquires 20,000 SharesThe Goldman Sachs Group (NYSE:GS) Insider Sells $222,562.50 in StockSEA (NYSE:SE) Stock: Insider Yanjun Wang Sells 800 SharesInsider Selling: Coupang (NYSE:CPNG) CAO Sells $75,334.35 in StockRecent ArticlesStarz Entertainment (NASDAQ:STRZ) Insider Acquires 460 Shares of StockLimoneira (NASDAQ:LMNR) Stock: Insider Gregory Hamm Sells 1,000 SharesSilynxcom (NYSEAMERICAN:SYNX) CEO Nir Klein Acquires 13,286 Shares of StockVolcon (NASDAQ:EMPD) Major Shareholder Sells 4,464 Shares of Company StockThe Gabelli Healthcare & Wellness Trust (NYSE:GRX) Major Shareholder Purchases 1,201 Shares of Company StockTPG RE Finance Trust (NYSE:TRTX) Director Purchases $12,860.00 in StockNayax (NASDAQ:NYAX) Insider Sells 276 Shares of StockAssembly Biosciences (NASDAQ:ASMB) Stock: Insider Jeanette Bjorkquist Sells 727 Shares